ACHE and Alzheimer disease: One pharmacological strategy for AD is the use of acetylcholinesterase inhibitors (AChEIs), which inhibit the breakdown of acetylcholine (ACh), and therefore increase its concentration in neuronal synapses to compensate for the loss of cholinergic neurons, which is characteristic of AD (2).